Released Jul 28, 2016, after the close
10-Q filed Jul 28, 2016, 28 days after period end · 0000917520-16-000092
Q2 2016 · 10-Q
Revenue$249.31M$249.31M +17.2% vs Q2 2015+5.3% vs Q1 2016
Net Income$12.76M$12.76M +155.2% vs Q2 2015−4.9% vs Q1 2016
EPS Diluted$0.16$0.16 +100.0% vs Q2 2015−11.1% vs Q1 2016
Gross Profit$159,744,000+16.2%
Operating Income$22,377,000−8.1%
Operating Cash Flowderived$38,079,000+36.1%
Free Cash Flowderived$29,812,000+62.4%
Margins · derived
Gross margin64.1%−0.5 pt vs Q2 2015
Operating margin9.0%−2.5 pt vs Q2 2015
Net margin5.1%+2.8 pt vs Q2 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | $249.31M | $212.67M | $231.35M | $205.55M |
| Net Income | $12.76M | $5.00M | $4.83M | $1.52M |
| EPS Diluted | $0.16 | $0.08 | $0.15 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR